2121Навчання для менеджерів середньої ланки: модуль 1. Управління холодовим ланцюгом, вакцинами та обладнанням для безпечного виконання ін’єкцій.Technical Documents · November 14, 2023
2122Навчання для менеджерів середньої ланки: модуль 4. Кураторська підтримка.Technical Documents · November 14, 2023
2123Навчання для менеджерів середньої ланки: модуль 2. Співпраця із громадами.Technical Documents · November 14, 2023
2124Access to Medicines and Health Products programme. annual report 2021Technical Documents · November 12, 2023
2125Policy dialogue on prison health: analysis and the way forward in the Portuguese context. 15–16 February 2023Technical Documents · November 12, 2023
2126Access to Medicines and Health Products programme. annual report 2022Technical Documents · November 12, 2023
2127WHO roadmap on uses of COVID-19 vaccines in the context of Omicron and high population immunity: an approach to optimize the global impact of COVID-19 vaccines at a time when Omicron and its sub-lineages are the dominant circulating variants of concern, based on public health goals, evolving epidemiology, and increasing population-level immunity, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, updated: 21 January 2022, updated: 30 March 2023, latest update:10 November 2023Technical Documents · November 9, 2023
2128Эпидемиологический надзор за факторами риска неинфекционных заболеваний в Европейском регионе ВОЗ. Обзор исследования STEPS в 2013–2019 гг.Technical Documents · November 9, 2023
2130Diagnostic testing for the monkeypox virus (MPXV): interim guidance, 9 November 2023Technical Documents · November 8, 2023
2131Обеспечение доступа к лекарственным средствам в борьбе с устойчивостью к противомикробным препаратамTechnical Documents · November 8, 2023
2132Ensuring access to medicines in the fight against antimicrobial resistanceTechnical Documents · November 8, 2023
2133Therapeutics and COVID-19: living guideline, 10 November 2023Technical Documents · November 8, 2023
2134WHO handbook for guidelines development: supplement: criteria for use of evidence to inform recommendations in World Health Organization guidelinesTechnical Documents · November 8, 2023
2135Healthy, prosperous lives for all in Italy: piloting the WHO model in three Italian regions during the COVID-19 pandemic: piloting the WHO model in three Italian regions during the COVID-19 pandemicTechnical Documents · November 8, 2023
2136Una vita sana e prospera per tutti in Italia: la sperimentazione del modello dell’OMS in tre regioni durante la crisi COVID-19Technical Documents · November 8, 2023
2137Noncommunicable disease risk factor surveillance in the WHO European Region: an overview of the STEPS survey 2013–2019Technical Documents · November 8, 2023
2138Making prisons and places of detention resilient to infectious diseases: the London conclusionsTechnical Documents · November 7, 2023
2139Policy briefs on health impact assessments and incorporating health into environmental assessments: an overviewTechnical Documents · November 7, 2023
2140Generic guidelines and tools: policy brief 4 on health impact assessments and incorporating health into environmental assessmentsTechnical Documents · November 7, 2023